Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Brazília
4 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Curitiba, Jaú, Joinville, Porto Alegre, Rio de Janeiro, Santo André, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00 - 3. fázisTaking peopleA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Jaú, Joinville, Porto Alegre, Salvador, Santos, São Paulo
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - 3. fázisTaking peopleIvosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- Where
- Curitiba, São Paulo
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT06465953 · EU 2023-510155-37-00 - 1/2. fázisTaking peoplePTCy and ATG for MSD and MUD Transplants
- Where
- Rio de Janeiro
- Életkor
- 18 év to 60 év
- People
- 50
- Run by
- Instituto Nacional de Cancer, Brazil
See details and how to joinNCT06299462